Colrain Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Buy |
148,954
+26,474
| +22% | +$2.04M | 4.14% | 13 |
|
|
2025
Q4 | $9.72M | Sell |
122,480
-8,725
| -7% | -$688K | 5.34% | 7 |
|
|
2025
Q3 | $9.89M | Buy |
131,205
+27,863
| +27% | +$1.91M | 5.63% | 6 |
|
|
2025
Q2 | $7.13M | Buy |
103,342
+242
| +0.2% | +$15.9K | 5.5% | 6 |
|
|
2025
Q1 | $6.99M | Buy |
103,100
+16,750
| +19% | +$1M | 5.97% | 6 |
|
|
2024
Q4 | $3.88M | Buy |
+86,350
| New | +$4.84M | 3.8% | 9 |
|
|
2022
Q3 | $5.69M | Buy |
59,700
+4,200
| +8% | +$416K | 9.5% | 1 |
|
|
2022
Q2 | $5.14M | Buy |
55,500
+2,400
| +5% | +$234K | 8.05% | 2 |
|
|
2022
Q1 | $5.37M | Buy |
53,100
+3,350
| +7% | +$352K | 7.5% | 3 |
|
|
2021
Q4 | $5.13M | Buy |
49,750
+1,000
| +2% | +$92.4K | 6.17% | 4 |
|
|
2021
Q3 | $4.14M | Buy |
48,750
+3,750
| +8% | +$314K | 7.75% | 3 |
|
|
2021
Q2 | $3.75M | Sell |
45,000
-47,885
| -52% | -$3.92M | 6.75% | 4 |
|
|
2021
Q1 | $6.66M | Buy |
92,885
+45,500
| +96% | +$3.31M | 6.86% | 5 |
|
|
2020
Q4 | $3.24M | Sell |
47,385
-5,500
| -10% | -$358K | 6.57% | 6 |
|
|
2020
Q3 | $3.09M | Sell |
52,885
-11,100
| -17% | -$691K | 7.45% | 3 |
|
|
2020
Q2 | $4.16M | Sell |
63,985
-22,000
| -26% | -$1.39M | 9.11% | 1 |
|
|
2020
Q1 | $5.1M | Sell |
85,985
-14,135
| -14% | -$944K | 9.59% | 1 |
|
|
2019
Q4 | $7.44M | Sell |
100,120
-6,850
| -6% | -$481K | 7.8% | 1 |
|
|
2019
Q3 | $6.75M | Buy |
106,970
+6,745
| +7% | +$400K | 7.43% | 1 |
|
|
2019
Q2 | $5.46M | Buy |
100,225
+1,600
| +2% | +$86.2K | 6.13% | 4 |
|
|
2019
Q1 | $5.32M | Buy |
98,625
+17,640
| +22% | +$1.09M | 6.24% | 2 |
|
|
2018
Q4 | $5.31M | Buy |
80,985
+2,000
| +3% | +$149K | 6.89% | 1 |
|
|
2018
Q3 | $6.22M | Buy |
78,985
+8,375
| +12% | +$599K | 6.64% | 1 |
|
|
2018
Q2 | $4.54M | Sell |
70,610
-4,300
| -6% | -$283K | 5.36% | 5 |
|
|
2018
Q1 | $4.66M | Buy |
74,910
+10,310
| +16% | +$740K | 4.93% | 6 |
|
|
2017
Q4 | $4.68M | Sell |
64,600
-23,663
| -27% | -$1.72M | 3.87% | 11 |
|
|
2017
Q3 | $7.18M | Sell |
88,263
-9,500
| -10% | -$751K | 3.3% | 9 |
|
|
2017
Q2 | $7.87M | Sell |
97,763
-22,110
| -18% | -$1.75M | 3.19% | 10 |
|
|
2017
Q1 | $9.41M | Sell |
119,873
-35,682
| -23% | -$2.85M | 2.83% | 11 |
|
|
2016
Q4 | $12.3M | Buy |
155,555
+32,930
| +27% | +$2.66M | 2.57% | 15 |
|
|
2016
Q3 | $10.9M | Sell |
122,625
-19,725
| -14% | -$1.86M | 2.47% | 20 |
|
|
2016
Q2 | $13.6M | Sell |
142,350
-13,950
| -9% | -$1.39M | 2.72% | 18 |
|
|
2016
Q1 | $16.2M | Sell |
156,300
-122,228
| -44% | -$11.9M | 2.82% | 17 |
|
|
2015
Q4 | $27.2M | Sell |
278,528
-13,372
| -5% | -$1.31M | 2.76% | 20 |
|
|
2015
Q3 | $28.2M | Sell |
291,900
-51,086
| -15% | -$5.37M | 2.94% | 14 |
|
|
2015
Q2 | $36M | Sell |
342,986
-45,350
| -12% | -$4.63M | 3.17% | 12 |
|
|
2015
Q1 | $40.1M | Sell |
388,336
-43,103
| -10% | -$4.36M | 3.34% | 9 |
|
|
2014
Q4 | $41.6M | Sell |
431,439
-67,600
| -14% | -$5.96M | 3.21% | 12 |
|
|
2014
Q3 | $39.7M | Sell |
499,039
-41,749
| -8% | -$3.29M | 2.96% | 13 |
|
|
2014
Q2 | $40.8M | Sell |
540,788
-44,761
| -8% | -$3.38M | 2.93% | 13 |
|
|
2014
Q1 | $43.8M | Sell |
585,549
-61,261
| -9% | -$4.33M | 3.26% | 11 |
|
|
2013
Q4 | $46.3M | Sell |
646,810
-77,340
| -11% | -$4.97M | 3.21% | 10 |
|
|
2013
Q3 | $41.1M | Sell |
724,150
-117,800
| -14% | -$7.02M | 3.06% | 10 |
|
|
2013
Q2 | $48.1M | Buy |
+841,950
| New | +$48.8M | 3.51% | 7 |
|
Other funds holding CVS
VCM
VPM
Colrain Capital's CVS Position: Q1 2026 in Review
Colrain Capital increased its CVS Health (CVS) stake by 22% in Q1 2026, buying an estimated $2.04M and bringing the position to 148,954 shares worth $10.7M. The position accounts for 4.14% of the portfolio, ranked #13.
Colrain Capital first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $48.1M in Q2 2013. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Colrain Capital held 148,954 shares of CVS Health worth $10.7M as of Q1 2026.
- Colrain Capital bought 26,474 CVS Health shares in Q1 2026, an estimated $2.04M.
- CVS Health made up 4.14% of Colrain Capital's portfolio in Q1 2026, its #13 holding.
- Colrain Capital first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
- Colrain Capital's CVS Health position peaked at $48.1M in Q2 2013.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Colrain Capital's 13F filing for Q1 2026, filed 12 May 2026.